Examining inpatient chemotherapy utilization among patients with cancer and impact on outcomes
The Oncologist · 2025
DOI: 10.1093/oncolo/oyaf214 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Oncologist, 2025. Verfasst von Giulia Petrone und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, United States. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
With the adoption of safer outpatient cancer care practices, much of cancer care has transitioned to outpatient settings, decreasing the need for inpatient systemic therapy (IST), which is associated with poorer end-of-life outcomes. We evaluated reasons for IST use, palliative care (PC) utilization, and outcomes among IST recipients to inform guidelines on appropriate IST use. Materials and methods We conducted a retrospective chart review of all IST admissions at an academic center from January 2016 to December 2017. Patients were stratified by solid tumor (ST) vs hematological malignancies (HM). We recorded IST urgency, response, mortality, and other variables. Descriptive statistics and odds ratios were estimated from logistic regression models with mixed effects to account for multiple admissions per patient.
Results
We analyzed 893 admissions (19% ST) among 620 patients. HM patients required frequent elective IST admissions than ST (P < .0001). ST patients more often received IST for non-urgent indications (P = .0032) during non-cancer-related admissions. ST patients had fewer responses to IST compared to HM (36% vs 70%; P < .0001). PC services were more likely utilized for ST vs HM patients (48% vs 14%; P < .0001) and were associated with increased rates of health care proxy assignment, code status change, and hospice discharge. Early 60-day mortality was higher for ST vs HM patients (17.3% vs 5.8%; P < .001), and most patients (55%) died inpatient during the index admission.
Conclusion
IST was overutilized in ST patients with poor response rates and significant early mortality. PC service utilization rates remain low but improved end-of-life transition planning.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, United States.
- Division of Hematology, Department of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH 43210, United States.
- Division of Hematology and Medical Oncology, Department of Internal Medicine, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY 10029, United States.
- Department of Hematology Oncology, Zucker School of Medicine, Northwell Health, Hempstead, NY 11549, United States.
- Department of Population Health Science and Policy, Icahn School of Medicine, New York, NY 10029, United States.
- Division of Clinical and Translational Sciences, Department of Internal Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030, United States.
ORCID-Profile: Giulia Petrone, Natalie S Berger
Förderung
- NCI NIH HHS
Zitieren
APA
Petrone, G., Handa, S., Anderson, J., Chowdhury, N., Kwon, D., Jain, P., Bhardwaj, A. S., Smith, C. B., & Berger, N. S. (2025). Examining inpatient chemotherapy utilization among patients with cancer and impact on outcomes. The Oncologist. https://doi.org/10.1093/oncolo/oyaf214
Vancouver
Petrone G, Handa S, Anderson J, Chowdhury N, Kwon D, Jain P, et al. Examining inpatient chemotherapy utilization among patients with cancer and impact on outcomes. The Oncologist. 2025. doi:10.1093/oncolo/oyaf214
BibTeX
@article{Petrone2025,
author = {Petrone, Giulia and Handa, Shivani and Anderson, Justine and Chowdhury, Nobel and Kwon, Deukwoo and Jain, Priya and Bhardwaj, Aarti S and Smith, Cardinale B and Berger, Natalie S},
title = {Examining inpatient chemotherapy utilization among patients with cancer and impact on outcomes},
journal = {The Oncologist},
year = {2025},
doi = {10.1093/oncolo/oyaf214}
}
EUVIMED